Alnylam Pharmaceuticals
ALNY
#565
Rank
โ‚ฌ36.66 B
Marketcap
277,56ย โ‚ฌ
Share price
-0.93%
Change (1 day)
4.48%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: โ‚ฌ36.66 Billion

As of February 2026 Alnylam Pharmaceuticals has a market cap of โ‚ฌ36.66 Billion. This makes Alnylam Pharmaceuticals the world's 565th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ36.66 B-18.61%
2025โ‚ฌ45.05 B52.74%
2024โ‚ฌ29.49 B35.74%
2023โ‚ฌ21.72 B-20.28%
2022โ‚ฌ27.25 B52.2%
2021โ‚ฌ17.90 B45.88%
2020โ‚ฌ12.27 B6.44%
2019โ‚ฌ11.53 B78.87%
2018โ‚ฌ6.44 B-38.59%
2017โ‚ฌ10.50 B243.79%
2016โ‚ฌ3.05 B-58.31%
2015โ‚ฌ7.32 B18.98%
2014โ‚ฌ6.15 B107.47%
2013โ‚ฌ2.96 B309.81%
2012โ‚ฌ0.72 B170.08%
2011โ‚ฌ0.26 B-14.57%
2010โ‚ฌ0.31 B-39%
2009โ‚ฌ0.51 B-29.77%
2008โ‚ฌ0.73 B-9.78%
2007โ‚ฌ0.81 B35.14%
2006โ‚ฌ0.60 B176.3%
2005โ‚ฌ0.21 B104.8%
2004โ‚ฌ0.10 B

End of Day market cap according to different sources

On Feb 5th, 2026 the market cap of Alnylam Pharmaceuticals was reported to be:

โ‚ฌ37.01 Billion
by Nasdaq info icon info icon
โ‚ฌ37.01 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
โ‚ฌ255.74 B 597.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ98.25 B 167.96%๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
โ‚ฌ70.23 B 91.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ1.63 B-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
โ‚ฌ0.47 B-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚ฌ0.83 B-97.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ34.24 B-6.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
โ‚ฌ7.64 B-79.16%๐Ÿ‡บ๐Ÿ‡ธ USA